bluebird bio Income Statement

Financials in millions EUR. Fiscal year is October - September.

Millions EUR. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Revenue	4,522	4,451	4,094	3,678	3,120	3,233
Revenue Growth (YoY)	4.99%	8.72%	11.32%	17.88%	-3.50%	-
Cost of Revenue	2,496	2,428	2,250	2,069	1,812	1,808
Gross Profit	2,026	2,023	1,844	1,609	1,308	1,424
Selling, General & Admin	943.4	937.1	863.8	819.4	791.2	779
Other Operating Expenses	331.9	367.5	303.5	278.5	231.8	206.6
Operating Expenses	1,607	1,637	1,486	1,430	1,389	1,391
Operating Income	419.6	386.3	357.9	178.3	-81	33.3
Interest Expense	-208.1	-280.3	-310.9	-36.5	-41.8	-24.9
Interest & Investment Income	-	6.7	4.4	2.5	0.4	48.8
Currency Exchange Gain (Loss)	7.3	7.3	6.1	-6.5	-3.2	-5.3
Other Non Operating Income (Expenses)	-33.6	-33.7	29.7	-265.4	-187.7	-217.6
EBT Excluding Unusual Items	185.2	86.3	87.2	-127.6	-313.3	-165.7
Impairment of Goodwill	-	-	-12.4	-231.9	-	-279.7
Gain (Loss) on Sale of Investments	-	-	-	-	-	0.1
Gain (Loss) on Sale of Assets	0.1	0.1	0.3	9.8	0.9	-
Asset Writedown	-15	-15	-14.7	-16.6	-36.7	-38.9
Other Unusual Items	7.3	7.3	2.3	2.6	2.6	13
Pretax Income	181.3	82.4	65.4	-356.9	-344	-469.4
Income Tax Expense	37.2	-1.6	48.7	-43.2	43.6	49.5
Net Income	144.1	84	16.7	-313.7	-387.6	-518.9
Net Income to Common	144.1	84	16.7	-313.7	-387.6	-518.9
Net Income Growth	386.82%	402.99%	-	-	-	-
Shares Outstanding (Basic)	108	92	75	0	0	-
Shares Outstanding (Diluted)	108	92	75	0	0	-
Shares Change (YoY)	123.52%	22.88%	153635.78%	10.00%	-	-
EPS (Basic)	1.33	0.91	0.22	-6430.26	-8739.57	-
EPS (Diluted)	1.33	0.91	0.22	-6430.26	-8739.57	-
EPS Growth	117.80%	309.32%	-	-	-	-
Free Cash Flow	478	532.3	475.2	382.5	277.9	385.8
Free Cash Flow Per Share	4.42	5.78	6.34	7840.52	6266.06	-
Gross Margin	44.81%	45.45%	45.04%	43.74%	41.93%	44.06%
Operating Margin	9.28%	8.68%	8.74%	4.85%	-2.60%	1.03%
Profit Margin	3.19%	1.89%	0.41%	-8.53%	-12.43%	-16.05%
Free Cash Flow Margin	10.57%	11.96%	11.61%	10.40%	8.91%	11.93%
EBITDA	499.8	452.8	423.3	259.8	5.7	150.3
EBITDA Margin	11.05%	10.17%	10.34%	7.07%	0.18%	4.65%
D&A For EBITDA	80.2	66.5	65.4	81.5	86.7	117
EBIT	419.6	386.3	357.9	178.3	-81	33.3
EBIT Margin	9.28%	8.68%	8.74%	4.85%	-2.60%	1.03%
Effective Tax Rate	20.52%	-	74.47%	-	-	-

Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.